Evidence map›Paper›PMID 31900898›Full record

ArticleNeurotoxicity research2020

Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer.

Ashley Henneghan, Vikram Rao, Rebecca A Harrison, Meghan Karuturi, Douglas W Blayney, Oxana Palesh, Shelli R Kesler

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicity research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Applications of machine learning and natural language processing to neurocognitive outcomes in posttreatment cancer survivors: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Review
  6. Article
  7. MRI Voxel Morphometry Shows Brain Volume Changes in Breast Cancer Survivors: Implications for Treatment.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. [Cognitive deficits with chemotherapy in women with breast cancer: a bibliographic revisión]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ashley HenneghanUniversity of Texas at Austin School of Nursing, 1710 Red River St, Austin, TX, 78701, USA. ahenneghan@utexas.edu.ORCID https://orcid.org/0000-0002-6733-1926
Vikram RaoUniversity of Texas at Austin School of Nursing, 1710 Red River St, Austin, TX, 78701, USA.
Rebecca A HarrisonDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 431, Houston, TX, 77030, USA.
Meghan KaruturiDepartment of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Unit 1354, 1155 Pressler St., Houston, TX, 77030, USA.
Douglas W BlayneyDivision of Medical Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Oxana PaleshDepartment of Psychiatry and Behavioral Sciences, Stanford University Cancer Institute, Stanford University, 401 Quarry Road, Office 2318, Stanford, CA, 94305, USA.
Shelli R KeslerUniversity of Texas at Austin School of Nursing, 1710 Red River St, Austin, TX, 78701, USA.
The University of Texas at Austin · USStanford University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)R01CA172145 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KESLER, SHELLI R, PALESH, OXANA G · 2012 to 2024
$3.3M
Brief Behavioral Intervention for Insomnia During ChemotherapyR01CA181659 · NCI · STANFORD UNIVERSITY · PI PALESH, OXANA G · 2014 to 2018
$3.1M
NCI NIH HHS R01 CA172145NCI NIH HHS R01CA172145NCI NIH HHS R01 CA181659
6 · The paper itself

Abstract

Chemotherapy-related cognitive impairment and associated brain changes may reflect accelerated brain aging; however, empirical evidence for this theory is limited. The purpose of this study was to measure brain aging in newly diagnosed patients with breast cancer treated with chemotherapy (n = 43) and compare its longitudinal change to that of controls (n = 50). Brain age indices, derived from cortical measures, were compared between women with breast cancer and matched healthy controls across 3 timepoints (time 1: pre-surgery, time 2: 1 month following chemotherapy completion, and time 3: 1-year post-chemotherapy). The breast cancer group showed a significant decrease in cortical thickness across the 3 timepoints (p < .001) and a trend towards significant increase in predicted brain age especially from pre-treatment (time 1) to post-chemotherapy (time 2) compared to controls (p = 0.08). Greater increase in predicted brain age was related to several clinical factors (HER-2 status, surgery type, and history of neoadjuvant chemotherapy) and greater decrease in cortical thickness was associated with greater decrease in performance on a verbal learning task from time 1 to time 3 (r = - 0.48, p < .01). This study demonstrated evidence of increased cortical brain aging in middle-aged patients with breast cancer following chemotherapy treatment that was associated with decreased verbal memory performance.

Indexed as

AdultAgedAgingAntineoplastic AgentsBrainBreast NeoplasmsCerebral CortexCross-Sectional StudiesFemaleHumansLongitudinal StudiesMiddle AgedNeuropsychological TestsAntineoplastic AgentsBreast cancerChemotherapy-related cognitive impairmentCortical brain ageMRINeuroimagingProspective study

Identifiers

PMID31900898
PMCPMC7089817
OpenAlexW2998184546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.